INTRODUCTION
The goal of the US Pharmacopeia (USP) is to promote public health by establishing and disseminating offi cially recognized standards of quality for and authoritative information about the use of medicines and health care technologies by health professionals, patients, and consumers (further information about USP ' s background, organization, and activities is available at www.usp.org/aboutUSP ). USP carries out this mission by, among other activities, continuous enhancements of 2 compendia, the United States Pharmacopeia ( USP ) and the National Formulary ( NF ), through publication of revisions to the texts. These revisions include addition of new text (eg, new monographs or General Chapters), changes to current text (eg, updated analytical procedures), and removal of text (eg, deletion of monographs for articles no longer available). Although the USP text is still in its fi rst edition, it is now available as USP 29 (ie, the 29th revision). Whereas the fi rst pharmacopeia, published in 1820, contained 621 monographs (a materia medica of 221 drugs, a secondary list of 71 drugs, and an untitled section of 329 preparations and compositions), 1 USP 29 contains more than 4000 ingredient and drug, dietary supplement, and other product monographs for therapeutic articles legally marketed in the United States. A similar pattern of enhancement has occurred for the NF , which fi rst appeared in 1888 with 435 formulas and came to USP in 1975 with 1009 2 ; NF 24 contains more than 355 excipient monographs. The variation in NF monographs can be explained in part by the inclusion or exclusion of formulas. For example, NF XV (1980) included 66 pages of monographs and 127 pages of antibiotic preparations. The latter were absent in NF XVI (1985) , which featured 91 pages of monographs. In 1995, USP placed dietary supplements in a separate section, further limiting the number of entries in NF . Continuous improvement arises for at least 2 reasons: (1) advances in analytical procedures, and (2) advances in the number and types of manufactured therapeutic articles.
This work was submitted on behalf of the US Pharmacopeia (USP) Council of Experts, Expert Committee Members (Table 1) , USP staff listed in USP29 NF24, pp xi-xii, xviixix, and xx-xxii. , and attending to General Chapter work (eg, dividing the General Chapter Chromatography <621> into smaller chapters). An early outcome of this inventory was the identifi cation of and posting on the USP Web site of a list of high-priority monographs that USP is seeking for off-patent drug substances, drug products, and excipients ( www.usp.org/USPNF/ submitMonograph/newMon.html ). Other important work of the Council ' s Expert Committees beyond these compendia may be considered in separate publications.
USP has a well-established process to allow revisions to USP -NF . For many monographs, a Sponsor will submit a Request for Revision for either a new monograph or a revision to an existing one, following processes outlined in an available Guideline . 3 For General Chapters, Sponsors may 
MONOGRAPHS: NEW REVISION APPROACHES
Creation of new monographs and revision of existing ones are top priorities for USP. USP has no authority to compel submission of information to support a public monograph. 4 Instead, over the years, USP has worked diligently to gain the cooperation of those manufacturers who understand and support the importance of a public quality standard. 5 USP has developed the following ways to work with these manufacturers:
1. USP will work diligently with fi rst-entry manufacturers to obtain monographs for consideration by the Council of Experts (see Guideline in reference 3, pp 1-3 This terminology is consistent with USP's Constitution and Bylaws, which frequently refer to USP and NF " and other authorized publications. " 6. USP will expand its development of monographs for compounded preparations, working to obtain needed information from the biomedical literature and with internal and external laboratories to develop needed stability and other quality information to allow a beyond-use date. 
MONOGRAPH WORK PLAN

RECENT LINE EXTENSIONS AND OTHER IMPROVEMENTS
USP is attempting to make information available to a wide variety of audiences in user-friendly formats. For example, USP -NF soon will be offered in 3 volumes to accommodate the increasing amount of content. Also, USP is creating new publications: Table 2 ). The plan may change depending on several factors, including Expert Committee and staff resources and focus, and the number and type of public comments received in response to a particular revision proposal. At the close of the 2005-2010 cycle, the Chair of the Council of Experts will report on the work of the Council of Experts to the USP Board of Trustees and to the Convention itself. Like the previous cycle ' s report, this report will focus heavily on progress in the execution of the work plan described in this article. 9 , 10 USP looks forward to celebrating the extraordinary work of its volunteers at the 2010 Convention. 
